A phase III, randomized, double-blind, placebo controlled trial to evaluate the efficacy & safety of Vpm 1002 & immuvac vaccones in preventing Tuberculosis (TB) in healthy household contacts of newly diagnosed sputum positive pulmonary TB patients

Accessibility Controls

Implementing Organization

Translational Health Science & Technology Institute, Haryana

Principal Investigator

Ms. N. Wadhwa

Associate Professor, Translational Health Science & Technology Institute, Haryana

Source

Extramural R&D Projects listed in NSTMIS database 2019-20

Related Research

View All

Quick Information

Area of Research

Medical Sciences

Focus Area

Task Force (TF)

Start Date

2019

End Date

2023

Status

Completed

Output

No. of Research Paper

Technologies (If Any)

No. of PhD Produced

Publications

No. of Patents

Filed : 00

Grant : 00

Accessibility Controls

Research Projects

A phase III, randomized, double-blind, placebo controlled trial to evaluate the efficacy & safety of Vpm 1002 & immuvac vaccones in preventing Tuberculosis (TB) in healthy household contacts of newly diagnosed sputum positive pulmonary TB patients

Implementing Organization

Source

Related Research

Funding Organization

Quick Information

Output

विज्ञान एवं प्रौद्योगिकी विभाग

Department of
Science and Technology

Accessibility Controls

Research Projects

A phase III, randomized, double-blind, placebo controlled trial to evaluate the efficacy & safety of Vpm 1002 & immuvac vaccones in preventing Tuberculosis (TB) in healthy household contacts of newly diagnosed sputum positive pulmonary TB patients

Implementing Organization

Source

Related Research

Funding Organization

Quick Information

Output

You are leaving this website